First Report of Clinical, Functional, and Molecular Investigation of Chronic Granulomatous Disease in Nine Jordanian Families

[11] Leto TL(2002)Functional analysis of NADPH oxidase in granulocytic cells expressing a Δ488-497 pg91-phox deletion mutant Biochim Biophys Acta 1586 316-330

[12] Gallin JI(2004)Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly Hum Genet 115 418-427

[13] Malech HL(2007)Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91 J Leukoc Biol 81 238-249

[14] Holland SM(2007)) case with a double missense mutation in the gp91-phox-cytosolique C-terminal tail Med Sci (Paris) 23 526-532

[15] Azuma H(1996)Functional analysis of two-amino acid substitution in gp91 Blood 87 1663-1681

[16] Oomi K(1998) in a patient with X-linked flavocytochrome- Am J Hum Genet 62 1320-1331

[17] Sasak I(2001)-positive chronic granulomatous disease by means of transgenic PLB-985 cells Blood 97 305-311

[18] Kawabata T(1996)Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly Hum Mutat 27 1218-1229

[19] Sakaino S(1968)The X Scand J Clin Lab Invest. 21 77-89

[20] Koyano T(1991) chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation Eur J Biochem. 202 649-655

[11] Leto TL(2002)Functional analysis of NADPH oxidase in granulocytic cells expressing a Δ488-497 pg91-phox deletion mutant Biochim Biophys Acta 1586 316-330

[12] Gallin JI(2004)Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly Hum Genet 115 418-427

[13] Malech HL(2007)Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91 J Leukoc Biol 81 238-249

[14] Holland SM(2007)) case with a double missense mutation in the gp91-phox-cytosolique C-terminal tail Med Sci (Paris) 23 526-532

[15] Azuma H(1996)Functional analysis of two-amino acid substitution in gp91 Blood 87 1663-1681

[16] Oomi K(1998) in a patient with X-linked flavocytochrome- Am J Hum Genet 62 1320-1331

[17] Sasak I(2001)-positive chronic granulomatous disease by means of transgenic PLB-985 cells Blood 97 305-311

[18] Kawabata T(1996)Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly Hum Mutat 27 1218-1229

[19] Sakaino S(1968)The X Scand J Clin Lab Invest. 21 77-89

[20] Koyano T(1991) chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation Eur J Biochem. 202 649-655